Investing Profile

Hakan Goker

InvestorVC

Managing Director at M Ventures (Merck)

m-ventures.com/enAmsterdam, Netherlands

Your Intro Paths to Hakan Goker

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Hakan Goker on

Current Investing Position

M Ventures (Merck) Managing Director

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

€600M

Hakan Goker is on these Sector & Stage Rankings

Hakan Goker's Investments On Record (13)

Company	StageDateRound Size	Total Raised
Actithera	Series AJul 2025$76M	$76M
Co-investors: Therese Liechtenstein (M Ventures (Merck)), Noga Yerushalmi (M Ventures (Merck))
ReproNovo	Series AMay 2025$65M	$65M
TRIMTECH Therapeutics	SeedMar 2025$31M	$31M
Co-investors: Michael Anstey (Cambridge Innovation Capital), Jeffrey Moore (MP Healthcare Venture Management), Laurence Barker (SV Health Investors)
Asceneuron	Series CJul 2024$100M Series ASep 2015$31M	$130M
Co-investors: Henrijette Richter (Soffinova Partners), Philip Scheltens (EQT Life Sciences)
iOnctura	Series BJun 2024$86M Series AJul 2020$6M Series AJan 2020$17M SeedJun 2017	$110M
Co-investors: Keno Gutierrez (BGV (BioGeneration Ventures)), Fiona MacLaughlin (Johnson & Johnson Innovation), Roel Bulthuis (INKEF Capital)
Nouscom	Series CNov 2023$73M	$140M
Co-investors: Scott Rocklage (5am Ventures), Sofia Ioannidou (Andera Partners), Guido Magni (Versant Ventures), Joachim Rothe (EQT Life Sciences), Genghis Lloyd-Harris (Abingworth)
Storm Therapeutics	Series BDec 2022$30M Series AMay 2019$18M Series AJun 2016$16M	$69M
Co-investors: Bruno Montanari (Seroba Life Sciences), Sakae Asanuma (Taiho Ventures)
Artios Pharma	Series CJul 2021$150M Series ASep 2016$33M	$270M
Co-investors: René Kuijten (EQT Life Sciences), Florian Müllershausen (Novartis Venture Fund), Raphael Wisniewski (Andera Partners), Barbara Dalton (Pfizer Venture Investments)